+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Calcium Channel Blocker"

Hypertrophic Cardiomyopathy- Pipeline Insight, 2025 - Product Thumbnail Image

Hypertrophic Cardiomyopathy- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Diabetic Cardiomyopathy - Pipeline Insight, 2025 - Product Thumbnail Image

Diabetic Cardiomyopathy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
From
From
From
Quinidine Sulfate - Global Strategic Business Report - Product Thumbnail Image

Quinidine Sulfate - Global Strategic Business Report

  • Report
  • September 2025
  • 175 Pages
  • Global
From
From
From
Cardiac Arrhythmias Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Cardiac Arrhythmias Therapeutics - Global Strategic Business Report

  • Report
  • September 2025
  • 183 Pages
  • Global
From
Amlodipine Besylate - Global Strategic Business Report - Product Thumbnail Image

Amlodipine Besylate - Global Strategic Business Report

  • Report
  • September 2025
  • 177 Pages
  • Global
From
Angina Pectoris Drugs - Global Strategic Business Report - Product Thumbnail Image

Angina Pectoris Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 196 Pages
  • Global
From
Anti-Ischemic Agents - Global Strategic Business Report - Product Thumbnail Image

Anti-Ischemic Agents - Global Strategic Business Report

  • Report
  • September 2025
  • 94 Pages
  • Global
From
Cardiovascular Drugs - Global Strategic Business Report - Product Thumbnail Image

Cardiovascular Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 413 Pages
  • Global
From
Anti-Hypertensive Drugs - Global Strategic Business Report - Product Thumbnail Image

Anti-Hypertensive Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 326 Pages
  • Global
From
Atrial Fibrillation - Pipeline Insight, 2025 - Product Thumbnail Image

Atrial Fibrillation - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 60 Pages
  • Global
From
Pulmonary Hypertension - Pipeline Insight, 2025 - Product Thumbnail Image

Pulmonary Hypertension - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Aneurysmal Subarachnoid Hemorrhage- Pipeline Insight, 2025 - Product Thumbnail Image

Aneurysmal Subarachnoid Hemorrhage- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Buerger's Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Buerger's Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Refractory Angina- Pipeline Insight, 2025 - Product Thumbnail Image

Refractory Angina- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

Calcium Channel Blockers (CCBs) are a class of drugs used to treat cardiovascular diseases such as hypertension, angina, and arrhythmias. They work by blocking the entry of calcium ions into the cells of the heart and blood vessels, thus reducing the force of contraction of the heart and dilating the blood vessels. This reduces the workload on the heart and lowers blood pressure. CCBs are also used to treat other conditions such as migraine headaches and Raynaud's phenomenon. CCBs are generally well tolerated and have few side effects. Common side effects include dizziness, headache, and swelling of the ankles. They may also interact with other medications, so it is important to discuss all medications with a doctor before taking CCBs. The CCB market is a major component of the cardiovascular drug market. It is a highly competitive market, with many companies offering a variety of CCBs. Some of the major companies in the market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Show Less Read more